RespireRx Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glen Rock, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RespireRx Pharmaceuticals Inc. has filed 926 SEC EDGAR filings since 30 Oct 1995

SEC filing history

Showing 1-7 of 7 matching filings.

Per page
25
Current page
1
SC 13D File 005-40457

SCHEDULE 13D

Filing date
19 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-40457

SCHEDULE 13D AMENDMENT NO. 1

Filing date
19 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-40457

SCHEDULE 13D

Filing date
22 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-40457

SC 13D/A

Filing date
22 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-40457

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
27 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-40457

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
07 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-40457

SCHEDULE 13D

Filing date
31 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .